Houreratou Barry
5PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 11, 2024
Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen.Houreratou Barry, Edouard Lhomme, Mathieu Surénaud
|Feb 24, 2024
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.Adeep Puri, Andrew J Pollard, Catherine Schmidt-Mutter
|Jan 11, 2022
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.Zacchaeus Anywaine, Houreratou Barry, Omu Anzala
|Nov 24, 2021
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study.Toussaint Rouamba, Houreratou Barry, Esperance Ouédraogo
|Oct 29, 2021
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.Houreratou Barry, Gaudensia Mutua, Hannah Kibuuka
Pageof 1
Frequent Collaborators
3 joint publications
Sodiomon Bienvenu Sirima
3 joint publications
Rodolphe Thiébaut
2 joint publications
Zacchaeus Anywaine
2 joint publications
Laura Richert
2 joint publications
Christine Lacabaratz
2 joint publications
M Juliana McElrath
2 joint publications
Kristen W Cohen
2 joint publications
Georgi Shukarev
2 joint publications
Cynthia Robinson
1 joint publications
Nicolas Meda
